Company / Profit Margin
Fortress Biotech, Inc. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-79.8%
FY2025
5-year range
-114.3% / -71.8%
FY2021-FY2025
Trend
-11.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 10 years, ranging from -5611.6% in FY2017 to -71.8% in FY2024.
Based on SEC 10-K filings.
-79.8% in FY2025 with a 5-year CAGR of +29.3%.
Improved from -114.3% to -79.8% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +14.3pp
- 5-Year Change
- +29.3pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 11.1% year-over-year.
- Peak profit margin was recorded in FY2024.
- Lowest profit margin in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -79.8% | -11.1% |
| FY2024 | -71.8% | +37.2% |
| FY2023 | -114.3% | -21.5% |
| FY2022 | -94.1% | +7.8% |
| FY2021 | -102.0% | +6.5% |
| FY2020 | -109.1% | +65.1% |
| FY2019 | -313.0% | +19.3% |
| FY2018 | -387.8% | +93.1% |
| FY2017 | -5611.6% | -137.6% |
| FY2016 | -2362.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026